ID
36624
Beskrivning
Study ID: 102394 Clinical Study ID: 102394 Study Title: A Phase IV, partially double-blind study to demonstrate non-inferiority of GSK Biologicals’ Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process) when administered as a single dose to subjects aged 2-30 yrs Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00227422 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results Generic Name: Meningococcal Serogroups A, C, W-135 and Y Vaccine Trade Name: Mencevax Study Indication: Infections, Meningococcal
Länk
http://www.pfizer.com/research/clinical_trials/trial_data_and_results
Nyckelord
Versioner (1)
- 2019-05-26 2019-05-26 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
26 maj 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process); NCT00227422
Similar models
Concomitant Vaccination
- StudyEvent: ODM
C0042196 (UMLS CUI-2)
C0042196 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])